LABBOZZETTA, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 7.060
EU - Europa 6.340
AS - Asia 3.318
SA - Sud America 541
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 108
OC - Oceania 4
Totale 17.746
Nazione #
US - Stati Uniti d'America 6.877
IT - Italia 3.152
SG - Singapore 1.123
RU - Federazione Russa 930
CN - Cina 819
FI - Finlandia 501
BR - Brasile 419
UA - Ucraina 351
HK - Hong Kong 346
DE - Germania 323
VN - Vietnam 318
PL - Polonia 195
FR - Francia 180
IE - Irlanda 180
GB - Regno Unito 167
JP - Giappone 124
NL - Olanda 114
BD - Bangladesh 107
IN - India 105
SE - Svezia 84
TR - Turchia 84
CA - Canada 74
KR - Corea 51
MX - Messico 46
AR - Argentina 37
IR - Iran 33
IQ - Iraq 32
MY - Malesia 32
BE - Belgio 26
VE - Venezuela 24
RO - Romania 23
ZA - Sudafrica 23
ES - Italia 21
MA - Marocco 20
PK - Pakistan 20
CI - Costa d'Avorio 19
BG - Bulgaria 18
CO - Colombia 17
UZ - Uzbekistan 17
CH - Svizzera 16
ID - Indonesia 16
AT - Austria 15
EC - Ecuador 15
EG - Egitto 14
JM - Giamaica 14
SA - Arabia Saudita 14
TN - Tunisia 12
PH - Filippine 11
CR - Costa Rica 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
CL - Cile 8
HN - Honduras 8
NP - Nepal 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
GR - Grecia 6
LB - Libano 6
NI - Nicaragua 6
PY - Paraguay 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
DZ - Algeria 5
EU - Europa 5
KZ - Kazakistan 5
PE - Perù 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
GT - Guatemala 4
MT - Malta 4
PA - Panama 4
PR - Porto Rico 4
TW - Taiwan 4
BO - Bolivia 3
JO - Giordania 3
SN - Senegal 3
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
OM - Oman 2
RS - Serbia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
Totale 17.364
Città #
Ashburn 819
Singapore 737
Fairfield 533
San Jose 509
Palermo 372
Chandler 340
Hong Kong 335
Woodbridge 314
Houston 307
Ann Arbor 289
Wilmington 259
Seattle 203
Jacksonville 195
Cambridge 183
Council Bluffs 177
Dublin 174
Zgierz 165
Moscow 161
Beijing 145
Santa Clara 142
Des Moines 137
Milan 125
Medford 123
Rome 122
Tokyo 119
Los Angeles 116
New York 116
Frankfurt am Main 108
Ho Chi Minh City 106
Nanjing 87
Dallas 86
The Dalles 81
Boardman 77
Hanoi 77
Helsinki 76
Princeton 76
Lauterbourg 75
Hefei 55
Tulsa 52
Buffalo 49
Altamura 47
San Diego 47
Catania 46
São Paulo 43
Dearborn 42
Lawrence 37
Naples 37
Venice 33
Bologna 32
Chicago 31
Izmir 31
Florence 30
Hebei 30
Verona 30
Atlanta 29
Shenyang 28
Brussels 23
Nanchang 23
Memphis 22
Shanghai 22
Brooklyn 21
Jinan 21
Messina 21
Changsha 20
Columbus 20
London 20
Napoli 20
Abidjan 19
Bremen 19
Ludwigshafen am Rhein 19
Denver 18
Falls Church 18
Kuala Lumpur 18
Salerno 18
Toronto 18
Orem 17
Phoenix 17
Rio de Janeiro 17
Turin 16
Warsaw 16
Jiaxing 15
Montreal 15
Munich 15
Ningbo 15
Nuremberg 15
Sofia 15
Amsterdam 14
Bari 14
Brescia 14
Hangzhou 14
Auburn Hills 13
Haiphong 13
Padova 13
Tashkent 13
Turku 13
Cagliari 12
Da Nang 12
Tianjin 12
Belo Horizonte 11
Capaci 11
Totale 9.527
Nome #
ANALISI DEI POLIMORFISMI DEI GENI CODIFICANTI PER L'ENZIMA UDP-GLUCURONILTRANSFERASI (UGT) E PER L'ENZIMA DIIDROPIRIMIDINA DEIDROGENASI (DPD), CORRELATI A MAGGIORE TOSSICITA' IN SEGUITO A TRATTAMENTO, RISPETTIVAMENTE, CON IRINOTECANO E CON 5-FLUOROURACILE IN SOGGETTI CON TUMORE COLON RETTALE (CRC). 2.068
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 666
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 310
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 291
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 289
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 273
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 265
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 257
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 255
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 255
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 252
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 249
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 249
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 240
Analisi dei polimorfismi dei geni codificanti per l’enzima UDP-glucuronosiltrasferasi (UGT) e per l’enzima diidropirimidina deidrogenasi (DPD), correlati a maggiore tossicità in seguito a trattamento, rispettivamente, con Irinotecano e con 5-Fluorouracile in soggetti con tumore colon rettale (CRC) 237
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 236
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 235
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 230
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 221
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 220
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 217
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 215
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 214
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 209
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 203
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 203
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 201
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 195
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 194
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 192
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 192
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 191
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 190
Unusual high dose of tacrolimus in liver transplant patient, a case report. 186
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 185
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 183
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 182
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 181
Evaluation of patients with thrombotic stroke by methionine loading oral curve 174
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 173
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 173
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 172
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 172
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 171
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 171
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 168
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 167
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 167
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 167
Evaluations and new relationships between renal failure and homocysteine plasma levels in patients with chronic renal failure 165
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 164
null 164
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 162
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 160
Evaluations and new relationship between renal failure and homocysteine plasma levels in patients with chronic renal failure. 160
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 160
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 153
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 151
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 150
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 149
Plasma homocysteine levels in patients with chronic renal failure 149
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 146
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 145
NF-κB is a potential pharmacological target in triple negative breast cancers. 142
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 141
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 140
Expression of a specific Thymidylate synthase polimorfic allele in metastatic colorectal patients is regulated by Myeloid Zinc Finger 1. 139
Plasma homocysteine levels in patients with chronic renal failure. 135
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 134
Potential role of the natural multi-targeted agent curcumin in the treatment of oral diseases. 133
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 132
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 131
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 131
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 130
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 125
Plasma omocysteine levels in patients with chronic renal failure 125
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 125
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 125
Design and synthesis of hybrid drugs based on curcumin scaffold 123
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 123
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 115
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 114
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 112
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 98
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 79
null 67
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 43
Totale 17.746
Categoria #
all - tutte 52.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022801 0 0 32 32 52 32 66 45 95 183 61 203
2022/20231.289 128 157 16 133 140 192 113 88 131 29 99 63
2023/20241.424 74 113 142 92 95 185 170 106 45 139 96 167
2024/20252.380 107 201 175 235 167 115 173 140 190 229 271 377
2025/20265.799 403 197 322 436 514 862 774 551 411 829 233 267
2026/2027729 258 227 244 0 0 0 0 0 0 0 0 0
Totale 17.746